Home |
Free Dividend Report |
Stock Splits Calendar |
GBIM Historical Stock Prices |
Preferred Stock Newsletter |
Top Option Ideas |
Stock Message Boards |
GBIM (GBIM) has the following price history information. Looking back at GBIM historical stock prices for the last five trading days, on November 02, 2021, GBIM opened at $0.35, traded as high as $0.35 and as low as $0.35, and closed at $0.35. Trading volume was a total of 0 shares. On November 03, 2021, GBIM opened at $0.35, traded as high as $0.35 and as low as $0.35, and closed at $0.35. Trading volume was a total of 0 shares. On November 04, 2021, GBIM opened at $0.35, traded as high as $0.35 and as low as $0.35, and closed at $0.35. Trading volume was a total of 0 shares. On November 05, 2021, GBIM opened at $0.35, traded as high as $0.35 and as low as $0.35, and closed at $0.35. Trading volume was a total of 0 shares. On November 08, 2021, GBIM opened at $0.35, traded as high as $0.35 and as low as $0.35, and closed at $0.35. Trading volume was a total of 9.40K shares.
GBIM Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into GBIM shares, starting with a $10,000 purchase of GBIM, and working forward through the historical stock price information to today.
Growth of $10,000.00 Without Dividends Reinvested |
||
Start date: | 07/03/2014 | |
End date: | 11/08/2021 | |
Start price/share: | $11.85 | |
End price/share: | $0.35 | |
Dividends collected/share: | $0.00 | |
Total return: | -97.05% | |
Average Annual Total Return: | -38.05% | |
Starting investment: | $10,000.00 | |
Ending investment: | $295.27 | |
Years: | 7.36 |
GBIM Historical Price Range | |||||
Date | Open | High | Low | Close | Volume |
11/02/2021 | $0.35 | $0.35 | $0.35 | $0.35 | 0 |
11/03/2021 | $0.35 | $0.35 | $0.35 | $0.35 | 0 |
11/04/2021 | $0.35 | $0.35 | $0.35 | $0.35 | 0 |
11/05/2021 | $0.35 | $0.35 | $0.35 | $0.35 | 0 |
11/08/2021 | $0.35 | $0.35 | $0.35 | $0.35 | 9.40K |
About GBIM |
GlobeImmune is a biopharmaceutical company focused on developing products for the treatment of cancer and infectious diseases based on its proprietary Tarmogen® platform. Co. has four Tarmogen product candidates in clinical evaluation for infectious disease and multiple cancer indications. Co.'s infectious disease product candidates are: GS-4774 for hepatitis B infection; GI-19000 for tuberculosis; GI-2010 for human immunodeficiency virus; and GI-18000 for hepatitis D infection. Co.'s oncology product candidates are: GI-6207 for medullary thyroid cancer; GI-6301 for Chordoma, breast cancer; as well as GI-4000 for resected pancreas cancer, non-small cell lung cancer, and colorectal cancer. |
GBIM Historical Closing Prices | |
Date | Close |
11/02/2021 | $0.35 |
11/03/2021 | $0.35 |
11/04/2021 | $0.35 |
11/05/2021 | $0.35 |
11/08/2021 | $0.35 |
Healthcare Historical Prices |
GBIM is categorized under the Healthcare sector; below are some other companies in the same sector:
GBSN Historical Stock Prices
Free GBIM Email Alerts:
|
GBIM Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2024, All Rights Reserved
Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.Want to receive our latest research absolutely free?
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.